Published in MAbs on September 24, 2009
Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. Nature (2012) 1.75
Principles of antibody-mediated TNF receptor activation. Cell Death Differ (2015) 0.84
Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice. Arthritis Res Ther (2012) 0.81
The solution structures of two human IgG1 antibodies show conformational stability and accommodate their C1q and FcγR ligands. J Biol Chem (2015) 0.81
Effect of growth hormone and IgG aggregates on dendritic cells activation and T-cells polarization. Immunol Cell Biol (2016) 0.75
Molecular characterization and functional activity of an IL-15 antagonist MutIL-15/Fc human fusion protein. Mol Pharm (2013) 0.75
Fc engineering approaches to enhance the agonism and effector functions of an anti-OX40 antibody. J Biol Chem (2016) 0.75
Functional optimization of agonistic antibodies to OX40 receptor with novel Fc mutations to promote antibody multimerization. MAbs (2017) 0.75
Rapid screening of IgG quality attributes - effects on Fc receptor binding. FEBS Open Bio (2017) 0.75
Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J (2000) 21.93
Fc receptors. Annu Rev Immunol (1991) 7.92
High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J Biol Chem (2000) 5.18
Fc receptor biology. Annu Rev Immunol (1997) 5.08
Effects of protein aggregates: an immunologic perspective. AAPS J (2006) 4.74
The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature (2000) 3.53
Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today (1993) 3.28
The clearance of antigen antibody complexes from the blood by the reticuloendothelial system. J Immunol (1959) 3.25
Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol (2006) 2.88
Binding of affinity cross-linked oligomers of IgG to cells bearing Fc receptors. J Immunol (1977) 2.74
Modern applications of analytical ultracentrifugation. Annu Rev Biophys Biomol Struct (1999) 2.56
Structure-immunogenicity relationships of therapeutic proteins. Pharm Res (2004) 2.39
The structure of a human type III Fcgamma receptor in complex with Fc. J Biol Chem (2001) 2.33
The glomerular mesangium. I. Kinetic studies of macromolecular uptake in normal and nephrotic rats. J Clin Invest (1972) 2.26
Molecular basis of Fc receptor function. Adv Immunol (1994) 2.24
Factors influencing the immunogenicity of therapeutic proteins. Nephrol Dial Transplant (2005) 2.07
B cell memory and the long-lived plasma cell. Curr Opin Immunol (1999) 2.03
Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice. Pharm Res (1997) 1.91
Immune responses to therapeutic proteins in humans--clinical significance, assessment and prediction. Curr Pharm Biotechnol (2002) 1.81
Association and dissociation of aggregated IgG from rat peritoneal macrophages. J Exp Med (1977) 1.61
Human Fc gamma RII, in the absence of other Fc gamma receptors, mediates a phagocytic signal. J Clin Invest (1991) 1.60
Isolation of cDNAs for two distinct human Fc receptors by ligand affinity cloning. EMBO J (1988) 1.60
IgG receptor polymorphisms: risk factors for disease. Immunogenetics (1998) 1.59
The localization of aggregated human -globulin in the spleens of normal mice. Immunology (1973) 1.57
Regulation of phagocytosis and [Ca2+]i flux by distinct regions of an Fc receptor. Science (1991) 1.48
Global analysis of a macromolecular interaction measured on BIAcore. Biochem Biophys Res Commun (1996) 1.42
Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr Opin Immunol (2002) 1.36
Human Fc gamma RIII: cloning, expression, and identification of the chromosomal locus of two Fc receptors for IgG. Proc Natl Acad Sci U S A (1989) 1.36
Recognition of immunoglobulins by Fcgamma receptors. Mol Immunol (2002) 1.25
Macrophage triggering by aggregated immunoglobulins. I. Delayed effect of IgG aggregates or immune complexes. J Immunol (1981) 1.24
Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J Immunol (1994) 1.23
Functional analysis of human Fc gamma RII (CD32) isoforms expressed in B lymphocytes. J Immunol (1994) 1.17
The mast cell IgG receptors and their roles in tissue inflammation. Immunol Rev (2007) 1.08
Properties of the Fc receptor on macrophages. Immunol Commun (1976) 1.07
Increased Fc receptor activity in monocytes from patients with rheumatoid arthritis: a study of monocyte binding and catabolism of soluble aggregates of IgG in vitro. J Immunol (1981) 1.05
Fcgamma receptors in autoimmune diseases. Eur J Clin Invest (2001) 0.96
Kupffer cell depletion in vivo results in preferential elimination of IgG aggregates and immune complexes via specific Fc receptors on rat liver endothelial cells. Clin Exp Immunol (1991) 0.87
IgG-Fc receptors and the clinical relevance of their polymorphisms. Wien Klin Wochenschr (2001) 0.86
The beta-glucuronidase release from macrophages activated by immune complexes of varying antigen/antibody ratio. Ann Immunol (Paris) (1979) 0.85
Nucleotide sequence of three cDNAs for the human high affinity Fc receptor (FcRI). Nucleic Acids Res (1988) 0.84
Tandemly repeated Fc domain augments binding avidities of antibodies for Fcgamma receptors, resulting in enhanced antibody-dependent cellular cytotoxicity. Mol Immunol (2008) 0.82
Immunoglobulin G Fc receptors of human leukocytes. Methods Enzymol (1987) 0.82
Role of Fc gamma receptors in the activation of neutrophils by soluble and insoluble immunoglobulin aggregates isolated from the synovial fluid of patients with rheumatoid arthritis. Ann Rheum Dis (1994) 0.81
Measurement of the binding activity of defined IgG aggregates to macrophage Fc receptors. Immunol Lett (1983) 0.76
Macrophage triggering by aggregated immunoglobulins. II. Comparison of IgE and IgG aggregates or immune complexes. Clin Exp Immunol (1984) 0.76
Characterization and function of MYPT2, a target subunit of myosin phosphatase in heart. Cell Signal (2006) 1.11
Pharmacokinetic, biodistribution, and biophysical profiles of TNF nanobodies conjugated to linear or branched poly(ethylene glycol). Bioconjug Chem (2012) 0.83
[Ex vivo expansion of CD34(+) CD59(+) cells from bone marrow of paroxysmal nocturnal hemoglobinuria patients]. Zhonghua Xue Ye Xue Za Zhi (2002) 0.75
[Proliferative capacity of the isolated single CD(34)(+) glycosylphosphatidylinesitol-anchored (GPI) protein negative and positive hematopoietic cells in paroxysmal nocturnal hemoglobinuria]. Zhonghua Xue Ye Xue Za Zhi (2002) 0.75